Cadila Healthcare Ltd has informed BSE that Board of Directors of the Company and the Board of Directors of Zydus Animal Health Limited (ZAHL), Liva Healthcare Limited (LHL) and Zydus Pharmaceuticals Limited (ZPL) at their respective meetings held on April 22, 2013, approved the amalgamation of ZAHL, LHL and ZPL with the Company. This is subject to and conditional upon requisite approvals and section being received thereof, including approvals and orders under section 391-394 of the Companies Act, 1956, as may be required. In terms of the Scheme ZAHL, LHL and ZPL will be amalgamated with the Company followed by the dissolution without winding up of the ZAHL, LHL and ZPL. Upon the Scheme being effective, in consideration of the transfer and vesting of the undertaking of ZAHL, LHL and ZPL (the transferor Company) in the Company in terms of the Scheme, all the equity shares issued by the Transferor Companies and held by the Company and its nominees shall stand cancelled and extinguished and in lieu thereof, no allotment of any shares in the Company shall be made. Hon'ble National Company Law Tribunal, Bench at Ahmedabad has approved the Scheme of Arrangement between Cadila Healthcare Limited and Zydus Healthcare Limited and their respective shareholders and creditors vide order dated May 18, 2017. (As Per BSE Announcement Dated On 19/05/2017)